BG105779A - Човешки антибиотични протеини - Google Patents

Човешки антибиотични протеини

Info

Publication number
BG105779A
BG105779A BG105779A BG10577901A BG105779A BG 105779 A BG105779 A BG 105779A BG 105779 A BG105779 A BG 105779A BG 10577901 A BG10577901 A BG 10577901A BG 105779 A BG105779 A BG 105779A
Authority
BG
Bulgaria
Prior art keywords
proteins
antibiotic proteins
human antibiotic
sap
utilization
Prior art date
Application number
BG105779A
Other languages
English (en)
Inventor
Enno Christophers
Jurgen Harder
Jens Schroder
Original Assignee
Enno Christophers
Jurgen Harder
Jens Schroder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19905128A external-priority patent/DE19905128A1/de
Priority claimed from DE1999149436 external-priority patent/DE19949436A1/de
Application filed by Enno Christophers, Jurgen Harder, Jens Schroder filed Critical Enno Christophers
Publication of BG105779A publication Critical patent/BG105779A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Materials Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до SAP-2 и SAP-3 протеини, проявяващи антибиотично действие, до метод за пречистване на някои антимикробни протеини, до тяхното използване за антибиотична терапия или за използване на клетките, трансфектирани с ДНК, кодираща протеини.
BG105779A 1999-02-01 2001-08-03 Човешки антибиотични протеини BG105779A (bg)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19905128A DE19905128A1 (de) 1999-02-01 1999-02-01 Humane antibiotische Proteine
DE1999149436 DE19949436A1 (de) 1999-10-08 1999-10-08 Mindestens zwei humane antibiotische Proteine
PCT/EP2000/000776 WO2000046245A2 (de) 1999-02-01 2000-02-01 Humane antibiotische proteine

Publications (1)

Publication Number Publication Date
BG105779A true BG105779A (bg) 2002-04-30

Family

ID=26051733

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105779A BG105779A (bg) 1999-02-01 2001-08-03 Човешки антибиотични протеини

Country Status (8)

Country Link
US (2) US7419781B1 (bg)
EP (1) EP1068232B1 (bg)
AT (1) ATE291586T1 (bg)
AU (1) AU2668400A (bg)
BG (1) BG105779A (bg)
CA (1) CA2371794C (bg)
DE (1) DE50009838D1 (bg)
WO (1) WO2000046245A2 (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
WO2000046245A2 (de) * 1999-02-01 2000-08-10 Schering Aktiengesellschaft Humane antibiotische proteine
US6809181B2 (en) 2000-06-01 2004-10-26 University Of Iowa Research Foundation Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
AU2001289641A1 (en) * 2000-07-11 2002-01-21 Ipf Pharmaceuticals Gmbh Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
AU2002227925A1 (en) * 2000-11-14 2002-05-27 Ipf Pharmaceuticals Gmbh Human beta-defensin-3
FR2879203A1 (fr) * 2004-12-09 2006-06-16 Univ Rennes I Etablissement Pu Peptides antimicrobiens, polypeptides comprenant lesdits peptides, procedes pour les preparer, genes codant pour lesdits peptides, vecteurs, organismes transformes et compositions les contenant
WO2006097689A2 (en) 2005-03-18 2006-09-21 Domantis Limited Antibodies against candida antigens
JP2009535027A (ja) * 2006-04-27 2009-10-01 シンガポール ヘルス サービシーズ ピーティーイー リミテッド 抗菌ペプチド
EP2399618A1 (en) * 2010-06-22 2011-12-28 Planton GmbH Antimicrobial medical devices
US20150072922A1 (en) * 2012-04-17 2015-03-12 The Research Institute At Nationwide Children's Hospital Rnase 7 antimicrobial peptides
MX2020000265A (es) 2017-07-07 2020-07-22 Epicentrx Inc Composiciones para la administración parenteral de agentes terapéuticos.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08507702A (ja) * 1993-01-12 1996-08-20 エム． ニューマン，ナンシー 見分けられない包帯アセンブリ
US5866119A (en) 1997-06-02 1999-02-02 Incyte Pharmaceuticals, Inc. Human ribonuclease
EP1012285B1 (en) 1997-09-10 2005-08-03 ZymoGenetics, Inc. Beta-defensins
EP0943679A1 (en) * 1998-03-13 1999-09-22 Innogenetics N.V. Novel RNase-like protein and its use
WO2000046245A2 (de) * 1999-02-01 2000-08-10 Schering Aktiengesellschaft Humane antibiotische proteine

Also Published As

Publication number Publication date
CA2371794C (en) 2013-10-29
WO2000046245A3 (de) 2000-11-23
ATE291586T1 (de) 2005-04-15
WO2000046245A2 (de) 2000-08-10
CA2371794A1 (en) 2000-08-10
WO2000046245A8 (de) 2001-03-22
US7419781B1 (en) 2008-09-02
US20090010996A1 (en) 2009-01-08
EP1068232A2 (de) 2001-01-17
DE50009838D1 (de) 2005-04-28
US8735097B2 (en) 2014-05-27
EP1068232B1 (de) 2005-03-23
AU2668400A (en) 2000-08-25

Similar Documents

Publication Publication Date Title
DK0870003T4 (da) Hydrobehandlingskatalysator: sammensætning, fremstilling og anvendelse deraf
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
HK1031884A1 (en) Prostaglandin agonists and their use to treat bonedisorders.
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
BG105779A (bg) Човешки антибиотични протеини
AU6246199A (en) Human interleukin-b50, therapeutic uses
AU5132099A (en) Hyperbaric oxygen therapy system
SI1268522T1 (sl) Novi antagonisti lhrh, njihova priprava in uporaba kot zdravila
EP1210416A4 (en) GENES CODING PROTEINS FOR DIAGNOSTIC, PREVENTIVE AND THERAPEUTIC USE
PL308074A1 (en) Derivatives of borone peptides, their production as well as their application in medical therapy
HK1048480A1 (zh) 編碼人α-CT型鈣通道的DNA
DE69422928D1 (de) Modifizierte maxadilan-protein, dessen herstellung und verwendung, und dem protein kodierende dns
AU6449198A (en) Biological treatment of wastewater
EP1218392A4 (en) GENE THE PROTEINS ENCODE WHICH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER USE HAVE
EP1194534A4 (en) NOVEL GENES ENCODING PROTEINS THAT CAN BE USED IN DIAGNOSTIC, PREVENTIVE, THERAPEUTIC OR OTHER AREAS
WO1998024482A3 (de) Verwendung von endothelin-konjugaten in der therapie, neue endothelin-konjugate, diese enthaltende mittel, sowie verfahren zu deren herstellung
AU2002241691A1 (en) Biologically active composites and methods for their production and use
BR9609364A (pt) Tratamento bacteriano para preservar ensilagem
AU6676100A (en) Improved treatment for acute physical insult to the central nervous system
EP1240198A4 (en) GENES ENCODING PROTEINS WITH PROGNOSTIC, DIAGNOSTIC, PREVENTIVE, THERAPEUTIC AND OTHER APPLICATIONS
AU8536698A (en) Lus-1 human protein, its production and use
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
AUPP063297A0 (en) Improvements to trolling, spinning and jigging devices
AU2002218108A1 (en) Novel polypeptide--- a regulatory protein 10.01 being related to human development and polynucleotide encoding it